Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 

Astellas Pharma : Astellas CSR Website Renewed -- Content Regarding Access to Health Added - (pdf 193KB)

04/01/2012| 10:20pm US/Eastern
Recommend:
0
Astellas CSR Website Renewed -- Content Regarding Access to Health Added -

April 2, 2012

Tokyo, Japan, April 2, 2012 - Astellas Pharma Inc. (Tokyo:4503,"Astellas") announced that it renewed its
CSR (Corporate Social Responsibility ) site (http://www.astellas.com/en/csr/index.html )today.
This renewal has been conducted to enable those who browse Astellas' site to better understand the compay's CSR-based management and its CSR activities. For example, CSR content headings such as CSR Topics," "CSR-Based Management" and "CSR Throughout Our Business Activities" have been added for visitors to navigate the site more easily. In addition, the site was enhanced with new content regarding Astellas' proactive support for Access to Health.1
Astellas regularly updates its CSR site to provide visitors with a clear understanding of Astellas' CSR-based management and its CSR activities.
CSR top page: http://www.astellas.com/en/csr/index.html
Access to Health page: http://www.astellas.com/en/csr/health/index.html

1Access to Health: Unmet medical needs remain in many therapeutic areas. Furthermore, there are many people who are unable to access adequate medical care due to poverty or weak health systems. These problems are recognized as "Access to Health" and the CSR site introduces the various activities Astellas is taking to address to these issues under our Access to Health mission statement.

Renewed CSR Site

For inquiries or additional information

Astellas Pharma Inc.

Corporate Communications

Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com/en

distributed by

This press release was issued by Astellas Pharma Inc. and was initially posted at http://www.astellas.com/en/corporate/news/pdf/120402_Eg.pdf . It was distributed, unedited and unaltered, by noodls on 2012-04-02 04:08:37 AM. The issuer is solely responsible for the accuracy of the information contained therein.

Recommend :
0
Partner Area
React to this article
 
Latest news on ASTELLAS PHARMA INC
5d ago ANALYSIS - BLACKSTONE AND PEERS HAVE: themselves
6d ago ASTELLAS PHARMA INC: AVEO and Astellas Announce Presentations of Tivozanib Clin..
6d ago Dish lines up banks to finance Sprint bid - sources
7d ago ASTELLAS PHARMA INC: FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mu..
05/13 ASTELLAS PHARMA INC: Reshaping research framework to enhance the ability to gen..
05/13DJAstellas, Daiichi Sankyo See New Drugs Propelling Growth
05/13 ASTELLAS PHARMA INC: Astellas Announces Cancellation of Treasury Stock
05/13 ASTELLAS PHARMA INC: Astellas Announces Issuance of Stock Acquisition Rights fo..
05/08ASTELLAS PHARMA INC: quaterly earnings release
05/07 ASTELLAS PHARMA INC: Astellas announces a3 (a-cube) selection results on public..
Advertisement
Chart
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
Astellas Pharma Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.